Quince Therapeutics, Inc. (QNCX): DEF 14A filed Aug 25, 2026

Form type
DEF 14A
Filing date
Aug 25, 2026
Accession number
0001193125-26-364220
Filer
Quince Therapeutics, Inc. (CIK 1662774)